These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24396025)

  • 1. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
    Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
    Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.
    Lu YY; Xu DC; Zhao YF; Zhu GF; Zhu MY; Liu WJ; Yu XJ; Chen W; Liu Z; Xu YW
    J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
    Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
    Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
    J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
    Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
    Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZNF307 (Zinc Finger Protein 307) Acts as a Negative Regulator of Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Liang C; Li YX; Hu QQ; Zheng WW; Niu N; Yang X; Wang ZR; Yu XD; Zhang BL; Song BL; Zhang ZR
    Hypertension; 2017 Apr; 69(4):615-624. PubMed ID: 28223477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
    Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
    Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
    Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.
    Xiong X; Liu Y; Mei Y; Peng J; Wang Z; Kong B; Zhong P; Xiong L; Quan D; Li Q; Wang G; Huang H
    Sci Rep; 2017 Feb; 7():41857. PubMed ID: 28165494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
    Chatterjee A; Mir SA; Dutta D; Mitra A; Pathak K; Sarkar S
    J Cell Physiol; 2011 Oct; 226(10):2543-54. PubMed ID: 21792911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
    Zhang DH; Zhang JL; Huang Z; Wu LM; Wang ZM; Li YP; Tian XY; Kong LY; Yao R; Zhang YZ
    J Am Heart Assoc; 2020 Nov; 9(22):e017751. PubMed ID: 33170082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
    Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.
    Dai J; Shen DF; Bian ZY; Zhou H; Gan HW; Zong J; Deng W; Yuan Y; Li F; Wu QQ; Gao L; Zhang R; Ma ZG; Li HL; Tang QZ
    PLoS One; 2013; 8(1):e53412. PubMed ID: 23349709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-κB signaling.
    Li Q; Wei G; Tao T
    Biochem Biophys Res Commun; 2019 Jan; 509(1):16-23. PubMed ID: 30581005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
    Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
    Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.